![](/img/cover-not-exists.png)
Careful patient selection may improve response rates to infliximab in inflammatory bowel disease
Callum B Pearce, Ian C LawranceVolume:
22
Year:
2007
Language:
english
Pages:
7
DOI:
10.1111/j.1440-1746.2006.04739.x
File:
PDF, 83 KB
english, 2007